Can I take Awiqli if I have Type 1 Diabetes?

What happens if I miss my ‘Insulin Day’? You can usually take it up to 3 days late. If more than 3 days have passed, skip the dose and wait for your next scheduled day. Never take a double dose.

What happens if I miss my ‘Insulin Day’?

Is it better than daily insulin? It is equally effective at lowering HbA1c, but significantly more convenient for patients who find daily shots difficult.

Is it better than daily insulin?

Will insurance cover Awiqli? Most US private insurers and Medicare Part D plans began adding Awiqli to their formularies in April 2026. Many offer a “Tier 3” or “Preferred Brand” status.

Will insurance cover Awiqli?

Does it work with a CGM? Yes, in 2026, many US doctors recommend using a CGM (like Dexcom or Libre) when starting Awiqli to monitor how your body responds over the 7-day cycle.

Does it work with a CGM?

Can I travel with it? Yes. Since it’s once-weekly, you may not even need to carry it for short trips. For longer trips, it should be kept in a cooling pouch until used.

Can I travel with it?

Is there a generic version? No. As a newly approved biologic, Awiqli will be under patent protection for several years.

Is there a generic version?

Does it cause more ‘lows’ than daily insulin? Clinical trials showed the risk of hypoglycemia is comparable to daily basal insulin, provided the dosing is followed correctly.

Does it cause more ‘lows’ than daily insulin?

What is the ‘loading dose’? When you first start, your doctor may give you a higher first dose to “saturate” your system so the once-weekly timing starts working immediately.

What is the ‘loading dose’?

Can I use it with Ozempic? Yes, many US patients in 2026 use a GLP-1 (like Ozempic) alongside a basal insulin (like Awiqli) for maximum glucose control and weight management.

Awiqli (Insulin Icodec) - Control Diabetes

Introduction

Awiqli (insulin icodec) is the first once-weekly basal insulin analogue approved by the FDA (March 2026) for the treatment of adults with Type 2 Diabetes mellitus. Before Awiqli, basal insulins (like Lantus or Levemir) required daily injections to maintain steady blood sugar levels. Awiqli uses a specialized molecular structure that binds to albumin in the bloodstream, allowing it to be released slowly and steadily over a full seven days. This innovation aims to reduce “needle fatigue” and improve medication adherence for patients who struggle with daily dosing.

Usage and Indications

In the US, Awiqli is FDA-approved for:

Type 2 Diabetes: To improve glycemic control in adult patients.
It is specifically used as a basal (long-acting) insulin, meant to provide a background level of insulin throughout the week. It is often used in combination with oral medications or short-acting “mealtime” insulins.

How to Take It (Dosage)

Form: Subcutaneous injection (pre-filled pen).
Frequency: Once weekly, on the same day each week.
Injection Sites: Thigh, upper arm, or abdomen.
Switching from Daily Insulin: In the US, clinical protocols for 2026 suggest that when switching from daily insulin to Awiqli, the first dose is typically a “loading dose” or a specifically calculated unit amount based on the previous daily total.
Flexibility: If a dose is missed, it can be taken within a specific window (usually up to 3 days late), but patients should return to their original “Day of the Week” schedule for the next dose.

Side Effects

The side effect profile is similar to other insulin products, but with specific considerations for its long-acting nature:

Hypoglycemia (Low Blood Sugar): The most common side effect. Because Awiqli stays in the system for a week, managing “lows” requires consistent monitoring.
Injection Site Reactions: Redness, swelling, or itching at the site of the shot.
Weight Gain: A common side effect of all insulin therapies.
Edema: Swollen ankles or feet due to fluid retention.
Lipodystrophy: Pitting or thickening of the skin at the injection site if sites are not rotated.

Precautions and Warnings

Never for Type 1 Diabetes: As of April 2026, Awiqli is not approved for Type 1 Diabetes in the US due to a higher risk of hypoglycemia in that population.
Hypoglycemia Awareness: Patients with “hypoglycemia unawareness” (those who don’t feel the symptoms of low blood sugar) must use Awiqli with extreme caution and ideally alongside a Continuous Glucose Monitor (CGM).
Renal and Hepatic Impairment: Dose adjustments may be necessary for patients with kidney or liver disease.
No Sharing: Like all insulin pens, Awiqli pens must never be shared between patients, even if the needle is changed.

Interactions

Beta-Blockers: May mask the symptoms of low blood sugar (like a racing heart).
Thiazolidinediones (TZDs): When used with insulins like Awiqli, these can increase the risk of heart failure.
Alcohol: Can either increase or decrease the blood-sugar-lowering effect of Awiqli and should be used with caution.

Storage

Unused Pens: Must be stored in the refrigerator (36°F to 46°F). Do not freeze.
In-Use Pen: Once a pen is started, it can typically be kept at room temperature (up to 86°F) for a specific number of days (refer to the 2026 package insert for the exact duration, usually 4–6 weeks).
Protect from Light: Keep the pen cap on when not in use.

FAQ

Can I take Awiqli if I have Type 1 Diabetes? No. As of its 2026 US launch, it is only approved for Type 2 Diabetes.
What happens if I miss my ‘Insulin Day’? You can usually take it up to 3 days late. If more than 3 days have passed, skip the dose and wait for your next scheduled day. Never take a double dose.
Is it better than daily insulin? It is equally effective at lowering HbA1c, but significantly more convenient for patients who find daily shots difficult.
Will insurance cover Awiqli? Most US private insurers and Medicare Part D plans began adding Awiqli to their formularies in April 2026. Many offer a “Tier 3” or “Preferred Brand” status.
Does it work with a CGM? Yes, in 2026, many US doctors recommend using a CGM (like Dexcom or Libre) when starting Awiqli to monitor how your body responds over the 7-day cycle.
Can I travel with it? Yes. Since it’s once-weekly, you may not even need to carry it for short trips. For longer trips, it should be kept in a cooling pouch until used.
Is there a generic version? No. As a newly approved biologic, Awiqli will be under patent protection for several years.
Does it cause more ‘lows’ than daily insulin? Clinical trials showed the risk of hypoglycemia is comparable to daily basal insulin, provided the dosing is followed correctly.
What is the ‘loading dose’? When you first start, your doctor may give you a higher first dose to “saturate” your system so the once-weekly timing starts working immediately.
Can I use it with Ozempic? Yes, many US patients in 2026 use a GLP-1 (like Ozempic) alongside a basal insulin (like Awiqli) for maximum glucose control and weight management.